Abstract
Although not commonly encountered in clinical practice, disorders of phosphate and amino acid transport are of major pathophysiological importance. Studies of these disorders have provided important insights into normal transport physiology and have served as a model of the way basic science principles can be used to explain clinical disease, and how clinical disease can provide new physiological principles. In addition, these disorders have provided much information on the genetics of transport, which forms the basis for sound genetic counseling.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Bijvoet, O. L. M. 1980. Indices for the measurement of renal handling of phosphate. In: Renal Handling of Phosphate. S. G. Massry and H. Fleisch, eds. Plenum Press, New York. pp. 1–37.
Agus, Z. S., S. Goldfarb, and A. Wasserstein. 1981. Disorders of calcium and phosphate balance. In: The Kidney, 2nd ed. B. M. Brenner and F. C.Rector, Jr., eds. W. B. Saunders, Philadelphia. pp. 940–1022.
Marshall, E. K., and A. L. Grafflin. 1933. Excretion of inorganic phosphate by the glomerular kidney. Proc. Soc. Exp. Biol. Med. 31: 44–46.
Wolbach, R. A. 1970. Phlorizin and renal phosphate secretion in the spiny dog fish—Squalus acanthias. Am. J. Physiol. 219: 886–888.
Walker, A. M., and C. C. Hudson. 1937. The role of the tubule in the excretion of inorganic phosphates by the amphibian kidney. Am. J. Physiol. 118: 167–173.
Clark, N. B., and W. H. Dantzler. 1972. Renal tubular transport of calcium and phosphate in snakes: Role of parathyroid hormone. Am. J. Physiol. 223: 1455–1468.
Levinsky, N. G., and D. G. Davidson. 1957. Renal action of parathyroid extract in the chicken. Am. J. Physiol. 191: 530–536.
Handler, J. S. 1962. A study of renal phosphate excretion in the dog. Am. J. Physiol. 202: 787–790.
Strickler, J. C., D. D. Thompson, R. M. Klose, and G. Giebisch. 1964. Micropuncture study of inorganic phosphate excretion in the rat. J. Clin. Invest. 43: 1596–1607.
Le Grimellec, C., N. Roinel, and F. Morel. 1974. Simultaneous Mg, Ca, P, K, and Cl analysis in rat tubular fluid. IV. During acute plasma phosphate loading. Pfluegers Arch. 346: 189–204.
Amiel, C., H. Kuntziger, and G. Richet. 1970. Micropuncture study of handling of phosphate by proximal and distal nephron in normal and parathyroidectomized rat: Evidence for distal reabsorption. Arch. Ges. Physiol. 317: 93–109.
Goldfarb, S., L. H. Beck, Z. S. Agus, and M. Goldberg. 1974. Dissociation between the sites of action of PTH and saline on renal phosphate reabsorption. Clin. Res. 22: 528A.
Agus, Z. S., J. B. Puschett, D. Senesky, and M. Goldberg. 1971. Mode of action of cyclic adenosine 3’,5’-monophosphate on renal tubular phosphate reabsorption in the dog. J. Clin. Invest. 50: 617–626.
Wan, S. F. 1974. Micropuncture studies of phosphate transport in the proximal tubule of the dog. J. Clin. Invest. 53: 143–153.
Agus, Z. S., L. B. Gardner, L. H. Beck, and M. Goldberg. 1973. Effects of parathyroid hormone on renal tubular reabsorption of calcium, sodium and phosphate. Am. J. Physiol. 224: 1143–1148.
Lambert, P. P., R. Vanderveiken, J. P. DeKoster, R. J. Kahn, and M. DeMyttenaere. 1964. Study of PO4 excretion by the stop-flow technique: Effects of PTH. Nephron. 1: 103–117.
Davis, B. B., L. H. Kedes, and J. V. Field. 1966. Demonstration of distal tubule flux of phosphate using modified stop-flow analysis. Metabolism 15: 482–491.
Le Grimellec, C., P. Poujeol, and C. de Rouffignac. 1975. 3H inulin and electrolyte concentrations in Bowman’s capsule in rat kidney. Pfluegers Arch. 354: 117–131.
Harris, C. A., P. G. Baer, E. Chirito, and J. H. Dirks. 1974. Composition of mammalian glomerular filtrate. Am. J. Physiol. 227: 972–976.
Staum, B. B., R. J. Hamburger, and M. Goldberg. 1972. Tracer microinjection study of renal tubular phosphate reabsorption in the rat. J. Clin. Invest. 51: 2271–2276.
Amiel, C. 1980. Sites of renal tubular reabsorption of phosphate. In: Renal Handling of Phosphate. S. G. Massry and H. Fleisch, eds. Plenum Press, New York. pp. 39–57.
Chiu, P. J. S., Z. S. Agus, and M. Goldberg. 1974. Effect of parathyroidectomy on renal phosphate transport in the rat. Clin. Res. 23: 520A.
Murayama, Y., F. Morel, and C. Le Grimellec. 1972. Phosphate, calcium and magnesium transfers in proximal tubules and loops of Henle, as measured by single nephron microperfusion experiments in the rat. Pfluegers Arch. 333: 1–16.
Haramati, A., F. G. Knox. 1981. Is phosphate reabsorbed by the distal nephron? Miner. Electrolyte Metab. 6: 165–173.
Jamison, R. L., and J. F. Arrascue. 1980. Calcium and phosphate reabsorption by the loop of Henle. Miner. Electrolyte Metab. 4: 97–105.
de Rouffignac, C., F. Morel, and N. Roinel. 1976. Micropuncture study of water and electrolyte movement along the loop of Henle in Psammomys with special references to magnesium, calcium and phosphorus. Pfluegers Arch. 344: 309–326.
Knox, F., H. Osswald, G. Marchand, W. Spielman, J. Haas, T. Berndt, and S. Youngberg. 1977. Phosphate transport along the nephron. Am. J. Physiol. 233: F261 - F268.
Goldfarb, S. 1980. Juxtamedullary and superficial nephron phosphate reabsorption in the cat. Am. J. Physiol. 239: F336 - F342.
Haas, J., T. Berndt, and F. Knox. 1978. Nephron heterogeneity of phosphate reabsorption. Am. J. Physiol. 233: F287 - F300.
Pastoriza-Munoz, E., R. Colindres, W. Lassiter, and C. Lechene. 1978. Effect of parathyroid hormone on phosphate reabsorption in rat distal convolution. Am. J. Physiol. 235: F321 - F330.
Harris, C., M. Burnatowska, J. Seely, R. Sutton, G. Quamme, and J. Dirks. 1979. Effects of parathyroid hormone on electrolyte transport in the hamster nephron. Am. J. Physiol. 236: F342 - F348.
Poujeol, P., B. Corman, C. Touvay, and C. de Rouffignac. 1977. Phosphate reabsorption in rat nephron terminal segments: Intrarenal heterogeneity and strain differences. Pfluegers Arch. 371: 39–44.
Peraino, R., and W. Suki. 1980. Phosphate transport by isolated rabbit cortical collecting tubule. Am. J. Physiol. 238: F358 - F362.
Shareghi, G. R., and Z. S. Agus. 1982. Magnesium transport in the cortical thick ascending limb of Henle’s loop of the rabbit. J. Clin. Invest. 69: 759–769.
Haas, J., T. Berndt, and F. Knox. 1980. Failure to detect papillary collecting duct phosphate reabsorption in thyroparathyroidectomized rats. Miner. Electrolyte Metab. 3: 146–150.
Beck, L. H., and M. Goldberg. 1974. Mechanism of the blunted phosphaturia in saline-loaded thyroparathyroidectomized dogs. Kidney Int. 6: 18–23.
Mudge, G. H., W. O. Berndt, and H. Valtin. 1973. Tubular transport of urea, glucose, phosphate, uric acid, sulfate and thiosulfate. In: Handbook of Physiology Section 8. J. Orloff and R. W. Berliner, eds. Williams & Wilkins, Baltimore, pp. 587–652.
Puschett, J. B., Z. S. Agus, D. Senesky, and M. Goldberg. 1972. Effects of saline loading and aortic obstruction on proximal phosphate transport. Am. J. Physiol. 223: 851–857.
Thompson, D. D., and H. H. Hiatt. 1957. Effects of phosphate loading and depletion on the renal excretion and reabsorption of inorganic phosphate. J. Clin. Invest. 36: 566–572.
Steele, T. H., and H. F. DeLuca. 1976. Influence of dietary phosphorus on renal phosphate reabsorption in the parathyroidectomized rat. J. Clin. Invest. 57: 867–874.
Trohler, H., J. P. Bonjour, and H. Fleisch. 1976. Inorganic phosphate homeostasis: Renal adaptation to the dietary intake in intact and thyroparathyroidectomized rats. J. Clin. Invest. 57: 264273.
Samiy, A. H., P. F. Hirsch, and A. G. Ramsay. 1965. Localization of phosphaturic effect of parathyroid hormone in the nephron of the dog. Am. J. Physiol. 208: 73–77.
Pullman, T. N., A. R. Lavender, I. Aho, and H. Rasmussen. 1960. Direct renal action of a purified parathyroid extract. Endocrinology 67: 570–582.
Bell, N. H., S. Avery, T. Sinha, C. M. Clark, Jr., D. O. Allen, and C. Johnston, Jr. 1972. Effects of dibutyryl cyclic adenosine 3’-5’-monophosphate and parathyroid extract on calcium and phosphorus metabolism in hypoparathyroidism and pseudohypoparathyroidism. J. Clin. Invest. 51: 816–823.
Hamburger, R. J., N. L. Lawson, and V. W. Dennis. 1974. Effects of cyclic adenosine nucleotides on fluid absorption by different segments of proximal tubule. Am. J. Physiol. 227: 396401.
Kinziger, H., C. Amiel, N. Roinel, and F. Morel. 1974. Effects of parathyroidectomy and cyclic AMP on renal transport of phosphate, calcium and magnesium. Am. J. Physiol. 227: 905–911.
Gekle, D. 1971. Der Einfluss von Parathormonauf die Nierenfunktion. I. Tierexperimentelle Untersuchungen. Arch. Ges. Physiol. 323: 96–120.
Nordin, B. E. C. 1960. The effect of intravenous parathyroid extract on urinary pH, bicarbonate and electrolyte excretion. Clin. Sci. 19: 311–319.
Puschett, J. B., and M. Goldberg. 1969. The relationship between the renal handling of phosphate and bicarbonate in man. J. Lab. Clin. Med. 73: 956–969.
Bank, N., H. S. Aneydjian, and S. W. Weinstein. 1974. A micro-perfusion study of phosphate reabsorption by the rat proximal renal tubule: Effect of parathyroid hormone. J. Clin. Invest. 54: 1040–1048.
Puschett, J. B. 1982. Are all of the renal tubular actions of parathyroid hormone mediated by the adenylate cyclase system? Miner. Electrolyte Metab. 7: 281–284.
Brazy, P. C., J. W. McKeown, R. H. Harris, and V. W. Dennis. 1980. Comparative effects of dietary phosphate, unilateral nephrectomy, and parathyroid hormone on phosphate transport by the rabbit proximal tubule. Kidney Int. 17: 788–800.
Haramati, A., J. A. Haas, and F. G. Knox. 1983. Adaptation of deep and superficial nephrons to changes in dietary phosphate intake. Am. J. Physiol. 244: F265 - F269.
Dominguez, J. H., R. W. Gray, and J. Lemann, Jr. 1976. Dietary phosphate deprivation in women and men: Effects on mineral and acid balances, parathyroid hormone and the metabolism of 25-OH vitamin D. J. Clin. Endocrinol. Metab. 43: 1056–1068.
Kreusser, W. J., K. Kurokawa, E. Aznar, and S. G. Massry. 1978. Phosphate depletion: Effect on renal inorganic phosphorus and adenine nucleotides, urinary phosphate and calcium, and calcium balances. Miner. Electrolyte Metab. 1: 30–42.
Muhlbauer, R. C., J. P. Bonjour, and H. Fleisch. 1977. Tubular localization of adaptation to dietary phosphate in rats. Am. J. Physiol. 233: F342 - F348.
Chambers, E. L., Jr., G. S. Gordan, L. Goldman, and E. C. Reifenstein, Jr. 1956. Tests for hyperparathyroidism: Tubular re-absorption of phosphate, phosphate deprivation, and calcium infusion. J. Clin. Endocrinol. Metab. 16: 1507–1521.
Steele, T. H. 1976. Renal resistance to parathyroid hormone during phosphorus deprivation. J. Clin. Invest. 58: 1461–1464.
Steele, T. H. 1977. Renal response to phosphorus deprivation: Effect of the parathyroids and bicarbonate. Kidney Int. 11: 327334.
Barrett, P. Q., J. M. Gertner, and H. Rasmussen. 1980. Effect of dietary phosphate on transport properties of pig renal microvillus vesicles. Am. J. Physiol. 239: F352 - F359.
Kempson, S. A., and T. P. Dousa. 1979. Phosphate transport across renal cortical brush border membrane vesicles from rats stabilized on a normal, high or low phosphate diet. Life Sci. 24: 881–888.
Stoll, R., R. Kinne, H. Murer, H. Fleisch, and J. P. Bonjour. 1979. Phosphate transport by rat renal brush border membrane vesicles: Influence of dietary phosphate, thyroparathyroidectomy, and 1,25-dihydroxyvitamin D3. Pfluegers Arch. 380: 47–52.
Harrison, H. E., and H. C. Harrison. 1941. The renal excretion of inorganic phosphate in relation to the action of vitamin D and parathyroid hormone. J. Clin. Invest. 20: 47–55.
Puschett, J. B., P. C. Fernandez, I. T. Boyle, R. W. Gray, J. L.Omdahl, and H. F. DeLuca. 1972. The acute renal tubular effects of 1,25-dihydroxycholecalciferol. Proc. Soc. Exp. Biol. Med. 141: 379–384.
Puschett, J. B., J. Moranz, and W. S. Kurnick. 1972. Evidence for a direct action of cholecalciferol and 25-hydroxycholecalciferol on the renal transport of phosphate, sodium and calcium. J. Clin. Invest. 51: 373–385.
Gekle, D., J. Stroder, and D. Rostock. 1971. The effect of vitamin D on renal inorganic phosphate reabsorption in normal rats, parathyroidectomized rats and rats with rickets. Pediatr. Res. 5: 4052.
Avioli, L. 1980. Effects of vitamin D and its metabolites on renal handling of phosphate. In: Renal Handling of Phosphate. S. G. Massry and H. Fleisch, eds. Plenum Press, New York. pp. 197–208.
Kinne, R., W. Berner, N. Hoffmann, and H. Murer. 1976. Phosphate transport by isolated renal and intestinal plasma membranes. Adv. Exp. Med. Biol. 81: 265–277.
Murer, H., H. Stern, G. Burchkhardt, C. Storelli, and R. Kinne. 1980. Sodium-dependent transport of inorganic phosphate across the renal brush border membrane. Adv. Exp. Med. Biol. 128: 11–23.
Cheng, L., and B. Sacktor. 1981. Sodium gradient-dependent phosphate transport in renal brush border membrane vesicles. J. Biol. Chem. 256: 1556–1564.
Aronson, P. S. 1981. Identifying secondary active solute transport in epithelia. Am. J. Physiol. 240: F1 - F11.
Barrett, P. Q., and P. S. Aronson. 1982. Glucose and alanine inhibition of phosphate transport in renal microvillus membrane vesicles. Am. J. Physiol. 242: F126 - F131.
Dousa, T. P., and S. A. Kempson. 1982. Regulation of renal brush border membrane transport of phosphate. Miner. Electrolyte Metab. 7: 113–121.
Rasmussen, H., D. B. P. Goodman, N. Friedman, E. Allen, and K. Kurokawa. 1976. Ionic control of metabolism. In: Handbook of Physiology, Section 7, Volume 7. G. D. Aurbach, ed. American Physiological Society, Washington, D.C. pp. 225–264.
Albright, F., A. M. Butler, and E. Bloomberg. 1937. Resistance to vitamin D therapy. Am. J. Dis. Child. 54: 529–547.
Saville, P. D., J. R. Nassim, F. H. Stevenson, L. Mulligan, and M. Carey. 1955. The effect of A.T. 10 on calcium and phosphorus metabolism in resistant rickets. Clin. Sci. 14: 489–499.
Stickler, G. B. 1963. External calcium and phosphorus metabolism in resistant rickets. J. Pediatr. 63: 942–948.
Russell, R. G. G., R. Smith, C. Preston, R. J. Walton, C. G. Woods, R. G. Henderson, and A. W. Norman. 1975. The effect of 1,25-dihydroxycholecalciferol on renal tubular reabsorption of phosphate, intestinal absorption of calcium and bone histology in hypophosphatemic renal tubular rickets. Clin. Sci. Mol. Med. 48: 177–186.
Williams, T. F., and R. W. Winters. 1972. Familial (hereditary) vitamin D-resistant rickets with hypophosphatemia. In: Metabolic Basis oflnheritedDisease. J. B. Stanbury, J. B. Wyngaarden, and D. W. Fredrickson, eds. McGraw-Hill, New York. pp. 1465–1485.
Brickman. A. S., J. W. Coburn, K. Kurokawa, J. E. Bethune, H. E. Harrison, and A. W. Norman. 1973. Actions of 1,25-dihydroxycholecalciferol in patients with hypophosphatemic vitamin D-resistant rickets. N. Engl. J. Med. 289: 495–498.
Earp, H. S., R. L. Ney, H. J. Gitelman, R. Richman, and H. F. DeLuca. 1970. Effects of 25-hydroxycholecalciferol in patients with familial hypophosphatemia and vitamin D-resistant rickets. N. Engl. J. Med. 283: 627–630.
Puschett, J. B., M. Genet, A. Rastegar, C. Anast, H. DeLuca, and A. Friedman. 1975. Long term therapy of vitamin D-resistant rickets with 25-hydroxycholecalciferol. Clin. Pharmacol. Ther. 17: 202–211.
Cohanim, M., H. F. DeLuca, and E. R. Yendt. 1972. Effect of prolonged treatment with 25-hydroxycholecalciferol in hypophosphatemic (vitamin D refractory) rickets and osteomalacia. Johns Hopkins Med. J. 131: 118–132.
Stickler, G. B., J. W. Beabout, and B. L. Riggs. 1970. Vitamin D-resistant rickets: Clinical experience with 41 typical familial hypophosphatemic patients and 2 atypical nonfamilial cases. Mayo Clin. Proc. 45: 197–218.
Reitz, R. E., and R. L. Weinstein. 1973. Parathyroid hormone secretion in familial vitamin D-resistant rickets. N. Engl. J. Med. 289: 941–945.
Glorieux, F. H., M. F. Holick, C. R. Scriver, and H. F. DeLuca. 1973. X-linked hypophosphataemic rickets: Inadequate therapeutic response to 1,25-dihydrocholecalciferol. Lancet 2: 287–289.
Glorieux, F., and C. R. Scriver. 1972. Loss of a parathyroid hormone sensitive component of phosphate transport in X-linked hypophosphatemia. Science 175: 997–999.
Barbour, B. H., S. J. Kronfield, and A. M. Pawlicki. 1966. Studies on the mechanism of phosphorus excretion in vitamin D-resistant rickets. Nephron. 3: 40–58.
Lewy, J. E., E. C. Carbana, H. A. Repetto, J. M. Canterbury, and E. Reiss. 1972. Serum parathyroid hormone in hypophosphatemic vitamin D-resistant rickets. J. Pediatr. 81: 294–300.
Field, M. H., and E. Reiss. 1960. Vitamin D-resistant rickets: The effect of calcium infusion on phosphate reabsorption. J. Clin. Invest. 30: 1807–1812.
Arnaud, C., F. Glorieux, and C. Scriver. 1971. Serum parathyroid hormone in X-linked hypophosphatemia. Science 173: 845–847.
Falls, W. F., N. W. Carter, F. C. Rector, and D. W. Seldin. 1968. Familial vitamin D-resistant rickets: Study of six cases with evaluation of the pathogenetic role of secondary hyperparathyroidism. Ann. Intern Med. 68: 553–560.
Balsan, S., and M. Garabedian. 1972. 25-Hydroxycholecalciferol: A comparative study in deficiency rickets and different types of resistant rickets. J. Clin. Invest. 51: 749–759.
Roof, B. S., C. F. Piel, and G. S. Gordan. 1972. Nature of defect for familial vitamin D-resistant rickets (VDRR) based on parathormone (PTH) assay. Clin. Res. 20: 624.
Puschett, J. B., A. Rastegar, M. Genet, C. Anast, and H. F. DeLuca. 1974. Effects of 25-hydroxycholecalciferol on urinary electrolyte excretion in hypophosphatemic rickets. Lancet 2: 920–926.
Insogna, K. L., A. E. Broadus, and J. M. Gertner. 1983. Impaired phosphorus conservation and 1,25 dihydroxyvitamin D generation during phosphorus deprivation in familial hypophosphatemic rickets. J. Clin. Invest. 71: 1562–1569.
Chesney, R. W., R. B. Mazess, P. Rose, A. J. Hamstra, H. DeLuca, and A. L. Breed. 1983. Long-term influence of calcitriol and supplemental phosphate in X-linked hypophosphatemic rickets. Pediatrics 71: 559–567.
Lyles, K. W., and M. K. Drezner. 1982. Parathyroid hormone effects on serum 1,25-dihydroxyvitamin D levels in patients with X-linked hypophosphatemic rickets: Evidence for abnormal 25hydroxyvitamin D-1-hydroxylase activity. J. Clin. Endocrinol. Metab. 54: 638–644.
Chesney, R. W., R. B. Mazess, P. Rose, A. Hamstra, and H. F. DeLuca. 1980. Supranormal 25-hydroxyvitamin D and subnormal 1,25-dihydroxyvitamin D. Am. J. Dis. Child. 134: 140–143.
Avioli, L. V., T. F. Williams, J. Lund, and H. F. DeLuca. 1967. Metabolism of D3–3H in vitamin D-resistant rickets aqd familial hypophosphatemia. J. Clin. Invest. 46: 1907–1915.
DeLuca, H. F., J. Lund, A. Rosenbloom, and C. C. Lobeck. 1967. Metabolism of tritiated vitamin D3 in familial vitamin D-resistant rickets with hypophosphatemia. J. Pediatr. 70: 828–832.
Lyles, K. W., A. G. Clark, and M. K. Drezner. 1982. Serum 1,25-dihydroxyvitamin D levels in subjects with X-linked hypophosphatemic rickets and osteomalaica. Calcif. Tissue Int. 34: 125–130.
Lyles, K. W., and M. K. Drezner. 1982. Parathyroid hormone effects on serum 1,25-dihydroxyvitamin D levels in patients with X-linked hypophosphatemic rickets: Evidence for abnormal 25hydroxyvitamin D-1-hydroxylase activity. J. Clin. Endocrinol. Metab. 54: 638–644.
Scriver, C. R., T. M. Reade, H. F. DeLuca, and A. J. Hamstra. 1978. Serum 1,25-dihydroxyvitamin D levels in normal subjects and in patients with hereditary rickets or bone disease. N. Engl. J. Med. 299: 976–980.
Drezner, M. K., and M. R. Haussler. 1979. Serum 1,25-dihydroxyvitamin D in bone disease. N. Engl. J. Med. 300: 435436.
Cassimos, C., C. Tsenghi, S. Michael, A. Liaromati, and K. Metaxotou. 1963. Continuous intravenous infusion of calcium in vitamin D deficient rickets. Pediatrics 32: 272–279.
Fraser, D., J. M. Leeming, E. A. Cerwenka, and K. Kenyeres. 1959. Studies of the pathogenesis of the high clearances of phosphate in hypophosphatemic vitamin D refractory rickets of the same type. Am. J. Dis. Child. 98: 586–587.
Lavender, A. R., and T. N. Pullman. 1963. Changes in inorganic phosphate excretion induced by renal arterial infusion of calcium. Am. J. Physiol. 205: 1025–1032.
Hahn, T. J., C. R. Scharp, L. R. Halstead, J. G. Haddad, D. M. Karl, and L. V. Avioli. 1975. Parathyroid hormone status and renal responsiveness in familial hypophosphatemic rickets. J. Clin. Endocrinol. Metab. 41: 926–937.
Riggs, L., R. G. Sprague, J. Jowsey, and F. T. Maher. 1969. Adult onset vitamin D-resistant hypophosphatemic osteomalacia: Effect of total parathyroidectomy. N. Engl. J. Med. 281: 762–766.
Kleerekopper, M., R. Coffey, T. Greco, S. Nichols, N. Cooke, W. Murphy, and L. Avioli. 1977. Hypercalcemic hyperparathyroidism in hypophosphatemic rickets. J. Clin. Endocrinol. Metab. 45: 86–94.
Lyles, K. W., C. R. McNamara, and M. K. Drezner. 1981. Coincidence of hypoparathyroidism and X-linked hypophosphatemic rickets: An experiment of nature illuminating the physiological factors which regulate the renal tubular defect. Am. Soc. Bone Miner. Res. 3: 22a.
Short, E., A. Sebastian, M. Spencer, and R. C. Morris. 1974. Hyperresponsiveness to the phosphaturic effect of parathyroid hormone in X-linked hypophosphatemic vitamin D-resistant rickets. J. Clin. Invest. 53: 75a.
Short, E. M., H. J. Binder, and L. E. Rosenberg. 1973. Familial hypophosphatemic rickets: Defective transport of inorganic phosphate by intestinal mucosa. Science 179: 700–702.
Haussier, M. R., M. Hughes, D. Baylink, E. Littledike, D. Cork, and M. Pitt. 1977. Influence of phosphate depletion on the biosynthesis and circulating level of 1,25 dihydroxyvitamin D. Adv. Exp. Med. Biol. 81: 233–250.
Tenehouse, H. S., C. R. Scriver, R. R. McInnes, and F. H. Glorieux. 1978. Renal handling of phosphate in vivo and in vitro by the X-linked hypophosphatemic male mouse: Evidence for a defect in the brush border membrane. Kidney Int. 14: 236244.
Glorieux, F. H., C. R. Scriver, E. M. Eicher, J. L. Southland, and R. Travers. 1974. X-linked hypophosphatemia in HYP/Y mouse: A model of the human disease. Pediatr. Res. 8: 389.
Eicher, E. M., J. L. Southard, C. R. Scriver, and F. H. Glorieux. 1976. Mouse model for human familial hypophosphatemic (vitamin D resistant) rickets. Proc. Natl. Acad. Sci. USA 73: 46674671.
Cowgill, L. D., S. Goldfarb, K. Lau, E. Slatopolsky, and Z. Agus. 1979. Evidence for an intrinsic renal defect in mice with genetic hypophosphatemic rickets. J. Clin. Invest. 63: 12031210.
Muhlbauer, R., J. P. Bonjour, and H. Fleisch. 1981. Tubular handling of phosphate (Pi) and Ca in X-linked hypophosphatemic mice: Defective adaptation to Pi restriction associated with a renal Ca leak. In: Hormonal Control of Calcium Metabolism. D. V. Cohn, R. V. Talmage, and J. L. Matthews, eds. Excerpta Medica, Amsterdam. p. 435.
Tenenhouse, H. S., C. R. Scriver, R. R. McInnes, and F. H. Glorieux. 1978. Renal handling of phosphate in vivo by the X-linked hypophosphatemic male mouse: Evidence for a defect in the brush border membrane. Kidney Int. 14: 236–244.
Tenenhouse, H. S., and C. R. Scriver. 1978. The defect in trans-cellular transport of phosphate in the nephron is located in brush-border membranes in X-linked hypophosphatemia (Hyp mouse model). Can. J. Biochem. 56: 640–645.
Tenenhouse, H. S., and C. R. Scriver. 1979. Renal brush border membrane adaptation to phosphorus deprivation in the HyplY mouse. Nature (London) 281: 225–227.
Tenenhouse, H. S., and C. R. Scriver. 1979. Renal adaptation to phosphate deprivation in the Hyp mouse with X-linked hypophosphatemia. Can. J. Biochem. 57: 938–946.
Meyer, R. A., R. W. Gray, and M. H. Meyer. 1980. Abnormal vitamin D metabolism in the X-linked hypophosphatemic mouse. Endocrinology 107: 1577–1581.
Lobaugh, B., and M. K. Drezner. 1983. Abnormal regulation of renal 25-hydroxy vitamin D-1-a-hydroxylase activity in the X-linked hypophosphatemic mouse. J. Clin. Invest. 71: 400–403.
Rasmussen, H., and C. Anast. 1983. Familial hypophosphatemic rickets and vitamin D-dependent rickets. In: The Metabolic Basis of Inherited Disease, 5th ed. J. B. Stanbury, J. B. Wyngaarden, D. S. Fredrickson, J. L. Goldstein, and M. S. Brown, eds. McGraw-Hill, New York. pp. 1743–1773.
Scriver, C. R., T. M. Reade, H. F. DeLuca, and A. J. Hamstra. 1978. Serum 1,25-dihydroxyvitamin D levels in normal subjects and in patients with hereditary rickets or bone disease. N. Engl. J. Med. 299: 976–979.
Reade, T. M., C. R. Scriver, F. H. Glorieux, B. Nogrady, E. Delvin, R. Poirier, F. Holick, and H. F. DeLuca. 1975. Response to crystalline la-hydroxyvitamin D3 in vitamin D-dependency. Pediatr. Res. 9: 593–599.
Balsan, S., M. Garabedian, M. Lieberherr, J. Gueris, and A. Ulmann. 1979. Serum 1,25-dihydroxyvitamin D concentrations in two different types of pseudo-deficiency rickets. In: Vitamin D: Basic Research and Its Clinical Application. A. W. Norman, K. Schaefer, D. V. Herrath, H.-G. Grigoleit, J. W. Colburn, H. F. DeLuca, E. B. Mawer, and T. Suda, eds. de Gruyter, Berlin. p. 1143.
DeLuca, H. F. 1978. Vitamin D metabolism and function. Arch. Intern. Med. 138: 836–847.
Prader, A., H. P. Kind, and H. F. DeLuca. 1976. Pseudovitamin D deficiency (vitamin D dependency). In: Inborn Errors of Calcium and Bone Metabolism. H. Bickel and J. Stern, eds. University Park Press, Baltimore. p. 115.
Fraser, D., S. W. Koch, H. P. Kind, M. F. Holick, Y. Tanaka, and H. F. DeLuca. 1973. Pathogenesis of hereditary vitamin D-dependent rickets: An inborn error of vitamin D metabolism involving defective conversion of 25-hydroxycholecalciferol to 1,25-dihydroxyvitamin D. N. Engl. J. Med. 289: 817–822.
Balsan, S., M. Garabedian, R. Sorginiard, M. F. Holick, and H. F. DeLuca. 1975. 1,25-Dihydroxyvitamin D3 and la-hydroxyvitamin D3 in children: Biologic and therapeutic effects in nutritional rickets and different types of vitamin D resistance. Pediatr. Res. 9: 586–593.
Brooks, M. H., N. H. Bell, L. Love, P. H. Stern, F Orfei, S. F. Queener, A. J. Hamstra, and H. F. DeLuca. 1978. Vitamin D-dependent rickets type II: Resistance of target organs to 1,25dihydroxyvitamin D. N. Engl. J. Med. 298: 996–999.
Marx, S. J., A. M. Speigel, E. M. Brown, D. G. Gardner, R. W. Downs, Jr., M. Attie, A. J. Hamstra, and H. F. DeLuca. 1978. A familial syndrome of decrease in sensitivity to 1,25-dihydroxyvitamin D. J. Clin. Endocrinol. Metab. 47: 1303–1310.
Zerwekh, J. E., K. Glass, J. Jowsey, and Y. C. Charles. 1979. A unique form of osteomalacia associated with end organ refractoriness to 1,25-dihydroxyvitamin D and apparent defective synthesis of 25-hydroxyvitamin D. J. Clin. Endoctinol. Metab. 49: 171–175.
Rosen, J. F., A. R. Fleischman, L. Finberg, A. J. Hamstra, and H. F. DeLuca. 1979. Rickets with alopecia: An inborn error of vitamin D metabolism. J. Pediatr. 94: 729–735.
Liberman, U. A., R. Samuel, A. Halabe, R. Kauli, S. Edelstein, Y. Weisman, S. E. Papapoulos, T. L. Clemens, L. J. Fraher, and J. L. H. O’Riordan. 1980. End-organ resistance to 1,25-dihydroxycholecalciferol. Lancet 1: 504–507.
Tsuchiya, Y., N. Matsuo, H. Cho, M. Kumagai, A. Yasaka, T. Suda, H. Orimo, and M. Shiraki. 1980. An unusual form of vitamin D-dependent rickets in a child: Alopecia and marked end-organ hyposensitivity to biologically active vitamin D. J. Clin. Endocrinol. Metab. 51: 685–690.
Eil, C., and S. J. Marx. 1981. Nuclear uptake of [3H11,25-dihydroxycholecalciferol in dispersed fibroblasts cultured from normal human skin. Proc. Nall. Acad. Sci. USA 78: 2562–2563.
Eil, C., V. A. Liberman, J. F. Rosen, and S. J. Marx. 1981. A cellular defect in hereditary vitamin D dependent rickets type II: Defective nuclear uptake of 1,25 dihydroxyvitamin D in cultured skin fibroblasts. N. Engl. J. Med. 304: 1588–1591.
Feldman, D. T. Chen, C. Cone, M. Hirst, S. Shani, A. Benderli, and Z. Hochberg. 1982. Vitamin D resistant rickets with alopecia: Cultured skin fibroblasts exhibit defective cytoplasmic receptors and unresponsiveness to 1,25(OH)2D3. J. Clin. Endocrinol. Met-ab. 55: 1020–1022.
Clemens, T. L., J. S. Adams, B. A. Gilcrest, Y. Tsuchiya, N. Matsuo, T. Suda, and M. F. Holick. 1981. Receptors for 1,25dihydroxyvitamin D3 in cultured human skin keratinocytes and fibroblasts: A model for the study of the mode of action of 1,25dihydroxyvitamin D3. Fifth Workshop on Vitamin D. p. 45.
Griffin, J. E., J. S. Chandler, M. R. Haussier, and J. E. Zerwekh. 1982. Receptor-positive resistance to 1,25-dihydroxyvitamin D: A new cause of osteomalacia associated with impaired induction of 24-hydroxylase in fibroblasts. Clin. Res. 30: 524A.
Fraser, D., S. W. Koch, P. Kind, M. F. Holick, Y. Tanaka, and H. DeLuca. 1973. Pathogenesis of hereditary vitamin D-dependent rickets. N. Engl. J. Med. 289: 817–822.
Arnaud, C., R. Maijer, T. Reade, C. R. Scriver, and D. T. Whelan. 1970. Vitamin D dependency: An inherited postnatal syndrome with secondary hyperparathyroidism. Pediatrics 46: 871–880.
Hamilton, R., J. Harrison, D. Fraser, I. Radde, R. Monecki, and L. Paunier. 1970. The small intestine in vitamin D-dependent rickets. Pediatrics 45: 364–373.
Fraser, D., S. W. Kooh, and C. R. Scriver. 1967. Hyperparathyroidism as the cause of hyperaminoaciduria and phosphaturia in human vitamin D deficiency. Pediatr. Res. 1: 425–435.
Suster, P., and J. W. Paala. 1970. Pseudovitamin D-deficiency rickets. J. Pediatr. 76: 937.
Arnaud, C., F. Glorieux, and C. R. Scriver. 1972. Serum parathyroid hormone levels in acquired vitamin D deficiency of infancy. Pediatrics 49: 837–840.
Scriver, C. R. 1974. Rickets and the pathogenesis of impaired tubular transport of phosphate and other solutes. Am. J. Med. 57: 43–49.
Grose, J. H., and C. R. Scriver. 1968. Parathyroid-dependent phosphaturia and aminoaciduria in the vitamin D-deficient rat. Am. J. Physiol. 214: 370–377.
Engstrom, G. W., H. F. DeLuca, J. W. Cramer, and H. Steen-bock. 1961. Vitamin D and urinary amino acid excretion in the rat. Proc. Soc. Exp. Biol. Med. 108: 105–108.
Chisholm, J. J., and H. E. Harrison. 1962. Aminoaciduria in vitamin D deficiency states in premature infants and older infants with rickets. J. Pediatr. 60: 206–219.
Cusworth, C. D., C. E. Dent, and C. R. Scriver. 1972. Primary hyperparathyroidism and hyperaminoaciduria. Clin. Chim. Acta 41: 355–361.
Weiss, I. W., K. Morgan, and J. M. Phang. 1972. Cyclic adenosine monophosphate-stimulated transport of amino acids in kidney cortex. J. Biol. Chem. 247: 760–764.
Drezner, M. K., and F. A. Neelon. 1983. Pseudohypoparathyroidism. In: The Metabolic Basis of Inherited Disease, 5th ed. J. B. Stanbury, J. B. Wyngaarden, D. S. Fredrickson, J. L. Goldstein, and M. S. Brown, eds. McGraw-Hill, New York. pp. 1508–1527.
Farfel, Z., and H. R. Bourne. 1982. Pseudohypoparathyroidism: Mutation affecting adenylate cyclase. Miner. Electrolyte Metab. 8: 227–236.
Albright, E., C. H. Burnett, P. H. Smith, and W. Parson. 1942. Pseudo-hypoparathyroidism, an example of Seabright-Bantam syndrome: Report of three cases. Endocrinology 30: 922–932.
Tashjian, A. H., Jr., A. G. Frantz, and J. B. Lee. 1966. Pseudohypoparathyroidism: Assays of parathyroid hormone and thyrocalcitonin. Proc. Natl. Acad. Sci. USA 56: 1138–1142.
Chase, L. R., G. L. Melson, and G. D. Aurbach. 1969. Pseudohypoparathyroidism: Defective excretion of 3’,5’-AMP in response to parathyroid hormone. J. Clin. Invest. 48: 1832–1844.
Lee, J. B., A. H. Tashjian, Jr., J. M. Streeto, and A. G. Frantz. 1968. Familial pseudohypoparathyroidism. N. Engl. J. Med. 279: 1179–1184.
Werder, E. A., J. A. Fischer, R. Illig, H. P. Kind, S. Bernasconi, A. Fanconi, and A. Prader. 1978. Pseudohypoparathyroidism and idiopathic hypoparathyroidism: Relationship between serum calcium and parathyroid hormone levels and urinary cyclic adenosine-3’,5’-monophosphate response to parathyroid extract. J. Clin. Endocrinol. Metab. 46: 872–879.
Drezner, M. K., R. A. Neelon, M. Haussier, H. T. McPherson, and H. E. Lebovitz. 1976. 1,25-Dihydroxycholecalciferol deficiency: The probable cause of hypocalcemia and metabolic bone disease in pseudohypoparathyroidism. J. Clin. Endocrinol. Met-ab. 42: 621–628.
Kidd, G. S., M. Schaaf, R. A. Adler, M. N. Lasman, and H. L. Wray. 1980. Skeletal responsiveness in pseudohypoparathyroidism: A spectrum of clinical disease. Am. J. Med. 68: 772781.
Drezner, M. K., F. A. Neelon, and H. E. Lebovitz. 1973. Pseudohypoparathyroidism type II: A possible defect in the reception of the cyclic AMP signal. N. Engl. J. Med. 289: 1056–1060.
Rodriguez, H. J., H. Villarreal, S. Klahr, and E. Slatopolsky. 1974. Pseudohypoparathyroidism type II: Restoration of normal renal responsiveness to parathyroid hormone by calcium administration. J. Clin. Endocrinol. Metab. 39: 693–701.
Bell, N. H., S. Avery, T. Sinha, L. C. Clark, Jr., D. O. Allen, and C. Johnston, Jr. 1972. Effects of dibutyryl cyclic adenosine 3’-5’monophosphate and parathyroid extract on calcium and phosphorus metabolism in hypoparathyroidism and pseudohypoparathyroidism. J. Clin. Invest. 51: 816–823.
Wertznian, R., and F. Murad. 1973. Effects of aminophylline, chlorpropamide and parathyroid extract on plasma and urinary cyclic AMP in pseudohypoparathyroidism. Clin. Res. 21: 89.
Marcus, R., J. F. Wilber, and G. D. Aurbach. 1971. Parathyroid hormone-sensitive adenyl cyclase from the renal cortex of a patient with pseudohypoparathyroidism. J. Clin. Endocrinol. Metab. 53: 537–541.
Drezner, M. K., and W. M. Burch, Jr. 1978. Altered activity of the nucleotide regulatory site in the parathyroid hormone-sensitive adenylate cyclase from the renal cortex of a patient with pseudohypoparathyroidism. J. Clin. Invest. 62: 1222–1227.
Ross, E. M., and A. G. Gilman. 1980. Biochemical properties of hormone-sensitive adenylate cyclase. Annu. Rev. Biochem. 49: 533–564.
Farfel, Z., A. S. Brickman, H. R. Kaslow, V. M. Brothers, and H. R. Bourne. 1980. Defect of receptor-cyclase coupling protein in pseudohypoparathyroidism. N. Engl. J. Med. 303: 237–242.
Farfel, Z., V. M. Brothers, A. S. Brickman, F. Conte, R. Neer, and H. R. Boume. 1981. Pseudohypoparathyroidism: Inheritance of deficient receptor-cyclase coupling activity. Proc. Natl. Acad. Sci. USA 78: 3098–3102.
Levine, M. D., R. W. Downs, Jr., M. Singer, S. J. Marx, G. D. Aurbach, and A. M. Spiegel. 1980. Deficient activity of guanine nucleotide regulatory protein in erythrocytes from patients with pseudohypoparathyroidism. Biochem. Biophys. Res. Commun. 94: 1319–1324.
Farfel, Z., and H. R. Bourne. 1980. Deficient activity of receptorcyclase coupling protein in platelets of patients with pseudohypoparathyroidism. J. Clin. Endocrinol. Metab. 51: 1202–1204.
Boume, H. R., H. R. Kaslow, A. S. Brickman, and Z. Farfel. 1981. Fibroblast defect in pseudohypoparathyroidism, type I: Reduced activity of receptor-cyclase coupling protein. J. Clin. Endocrinol. Metab. 53: 636–640.
Farfel, Z., M. Abood, and H. R. Bourne. 1982. Deficient activity of receptor-cyclase coupling protein in virus-transformed lymphoblaste of patients with pseudohypoparathyroidism. J. Clin. Endocrinol. Metab. 55: 113–117.
Fischer, J. A., 1981. Biologically inactive parathyroid hormone in pseudohypoparathyroidism-type I (PHP-I). In: Hormonal Control of Calcium Metabolism: Proceedings of the Seventh International Conference on Calcium Regulating Hormones. D. V. Cohn, R. V. Talmage, and L. J. Matthews, eds. Excerpta Medica, Amsterdam.
Sinha, T. K., D. O. Allen, S. F. Queener, and N. H. Bell. 1977. Effects of acetazolamide on the renal excretion of phosphate in hypoparathyroidism and pseudohypoparathyroidism. J. Lab. Clin. Med. 89: 1188–1197.
McDonald, K. M. 1972. Responsiveness of bone to parathyroid extract in siblings with pseudohypoparathyroidism. Metab. Clin. Exp. 21: 521–531.
Bell, N. H., E. S. Gerard, and F. C. Bartter. 1963. Pseudohypoparathyroidism with osteitis fibrosa cystica and impaired absorption of calcium. J. Clin. Endocrinol. Metab. 23: 759–772.
Lambert, P. W., B. W. Hollis, N. H. Bell, and S. Epstein. 1980. Demonstration of a lack of change in serum 1a,25-dihydroxyvitamin D in response to parathyroid extract in pseudohypoparathyroidism. J. Clin. Invest. 66: 782–791.
Moses, A. M., N. Breslau, and R. Coulson. 1976. Renal responses to PTH in patients with hormone-resistant (pseudo) hypoparathyroidism. Am. J. Med. 61: 184.
Kolb, F. O., and H. L. Steinbach. 1962. Pseudohypoparathyroidism with secondary hyperparathyroidism and osteitis fibrosa. J. Clin. Endocrinol. Metab. 22: 59.
Singleton, E. B., and C. T. Teng. 1962. Pseudohypoparathyroidism with bone changes simulating hyperparathyroidism: Report of a case. Radiology 78: 388.
Bell, N. H., E. S. Gerard, and F. C. Bartter. 1963. Pseudohypoparathyroidism with osteitis fibrosa cystica and impaired absorption of calcium. J. Clin. Endocrinol. Metab. 23: 759.
Frame, B., C. A. Hanson, H. M. Frost, M. Block, and A. R. Amstein. 1972. Renal resistance to parathyroid hormone with osteitis fibrosa: “Pseudohypohyperparathyroidism.” Am. J. Med. 52: 311.
Wilson, J. D., and D. R. Hadden. 1980. Pseudohypoparathyroidism presenting with rickets. J. Clin. Endocrinol. Metab. 51: 1184–1189.
Sinha, T. K., H. F. DeLuca, and N. H. Bell. 1977. Evidence for a defect in the formation of 1,25-dihydroxyvitamin D in pseudohypoparathyroidism. Metab. Clin. Exp. 26: 731–738.
Metz, S. A., D. J. Baylink, M. R. Hughes, M. R. Hauser, and R. P. Robertson. 1977. Selective deficiency of 1,25 dihydroxycholecalciferol: A cause of isolated skeletal resistance to parathyroid hormone. N. Engl. J. Med. 97: 1084–1090.
Mason, R. 5., D. Lissner, and S. Posen. 1980. Parathyroid hormone effect on 1,25-dihydroxyvitamin D in hypoparathyroidism. Ann. Intern. Med. 92: 260.
Aksnes, L., and D. Aarskog. 1980. Effect of parathyroid hormone on 1,25-dihydroxyvitamin D formation in type 1 pseudohypoparathyroidism. J. Clin. Endocrinol. Metab. 51: 1223.
Stogmann, W., and J. A. Fischer. 1975. Pseudohypoparathyroidism: Disappearance of the resistance of parathyroid extract during treatment with vitamin D. Am. J. Med. 59: 140.
Kind, H. P., D. K. Parkinson, S. M. Suh, D. Fraser, and S. W. Kooh. 1973. Parathyroid hormone response and effects of vitamin D in hypoparathyroidism and pseudohypoparathyroidism. Abstr. Endocr. Soc. 55: 164.
Kooh, S. W., D. Fraser, H. F. DeLuca, M. F. Holick, R. E. Belsey, M. B. Clark, and T. M. Murray. 1975. Treatment of hypoparathyroidism and pseudohypoparathyroidism with metabolites of vitamin D: Evidence for impaired conversion of 25-hydroxyvitamin D to 1,25-dihydroxyvitamin D. N. Engl. J. Med. 293: 840.
Werder, W. A., H. P. Kind, F. Egert, J. A. Fischer, and A. Prader. 1976. Effective long term treatment of pseudohypoparathyroidism with oral la-hydroxy-and 1,25-dihydroxyvitamin D in pseudohypoparathyroidism. J. Pediatr. 89: 266.
Davies, M., L. F. Hill, C. M. Taylor, and S. W. Stanbury. 1977. 1,25-Dihydroxycholecalciferol in hypoparathyroidism. Lancet 1: 55.
Salassa, R. M., J. Jowsey, and C. D. Arnaud. 1970. Hypophosphatemic osteomalacia associated with nonendocrine tumors. N. Engl. J. Med. 283: 65–70.
Evans, D. J., and J. G. Azzopardi. 1972. Distinctive tumors of bone and soft tissue causing acquired vitamin D-resistant osteomalacia. Lancet 1: 353–354.
Prader, A., R. Illig, E. Uehlinger, and G. Stadler, 1959. Rachitis in Folge Knochentumors. Helv. Paediatr. Acta 14: 554–565.
Dent, C. E., and M. Friedman. 1964. Hypophosphatemic osteomalacia with complete recovery. Br. Med. J. 1: 1676–1679.
Hauge, B. N. 1956. Vitamin D-resistant osteomalacia. Acta Med. Scand. 153: 271–282.
Yoshikawa, S., M. Kawabata, Y. Hatsuyama, O. Hosokawa, and T. Fujita. 1964. Atypical vitamin D-resistant osteomalacia. J. Bone Jt. Surg. Am. Vol. 46: 998–1107.
Case Records of the Massachusetts General Hospital (Case 38–1965). 1964. N. Engl. J. Med. 273: 494–504.
Drezner, M. K., and M. N. Feinglos. 1977. Osteomalacia due to 1,25-dihydroxycholecalciferol deficiency: Association with a giant cell tumor of bone. J. Clin. Invest. 60: 1046–1053.
Olefsky, J., R. Kempson, H. Jones, and G. Reaven. 1972. “Tertiary” hyperparathyroidism and apparent “cure” of vitamin-Dresistant rickets after removal of an ossifying mesenchymal tumor of the pharynx. N. Engl. J. Med. 286:740–745.
Wyman, A. L., F. J. Paradinas, and J. R. Daly. 1977. Hypophosphataemic osteomalacia associated with a malignant tumor of the tibia: Report of a case. J. Clin. Pathol. 30: 328–335.
McCance, R. A. 1947. Osteomalacia with Looser’s nodes (Milkman’s syndrome) due to a raised resistance to vitamin D acquired about the age of 15 years. Q. J. Med. 16: 33–50.
Pollack, J. A., A. L. Schiller, and J. D. Crawford. 1973. Rickets and myopathy cured by removal of a nonossifying fibroma of bone. Pediatrics 52: 364–371.
Linovitz, R. J., D. Resnick, P. Keissling, J. J. Kondon, B. Sehler, R. J. Wejdl, J. H. Rowe, and L. J. Deftos. 1976. Tumor-induced osteomalacia and rickets: A surgically curable syndrome. J. Bone Jt. Surg. Am. Vol. 58A: 419–423.
Wilhoite, D. R. 1975. Acquired rickets and solitary bone tumor: The question of a causal relationship. Clin. Orthop. Relat. Res. 109: 210–211.
Sweet, R. A., J. L. Males, A. J. Hamstra, and H. F. DeLuca. 1980. Vitamin D metabolite levels in oncogenic osteomalacia. Ann. Int. Med. 93: 279–280.
Lyles, K., W. R. Berry, M. Haussier, J. M. Harrelson, and M. K. Drezner. 1980. Hypophosphatemic osteomalacia: Association with prostatic carcinoma. Ann. Intern. Med. 93: 275–278.
Tanaka, Y., and H. F. DeLuca. 1974. Role of 1,25-dihydroxyvitamin D3 in maintaining serum phosphorus and curing rickets. Pro.^ Nat!. Acad. Sci. USA 71: 1040–1044.
Branar, N., M. Yaron, and J. W. Coburn. 1977. Interactions between parathyroid hormone and I,25(OH)2-vitamin D3 on renal handling of phosphate by the dog. Proceedings of the Third Workshop on Vitamin D. de Gruyter, Berlin.
Stewart, A. F., R. Horst, L. J. Deftos, E. C. Cadman, R. Lang, and A. E. Broadus. 1980. Biochemical evaluation of patients with cancer associated hypercalcemia: Evidence for humoral and non-humoral groups. N. Engl. J. Med. 303: 1377–1383.
Stewart, A. F. 1982. Is there a role flat parathyroid hormone in humoral hypercalcemia of malignancy?Miner. ElectrolyteMetab. 8: 215–226.
Stewart, A. F., K. L. Insogna, D. Goltzman, and A. E. Broadus. 1983. Identification of adenylate cyclase-stimulating activity and cytochemical glucose-6-phosphate dehydrogenase-stimulating activity in extracts of tumors from patients with humoral hypercalcemia of malignancy. Proc. Nat!. Acad. Sci. USA 80: 14541458.
Massry, S. G., R. M. Friedler, and J. W. Cobum. 1973. Excretion of phosphate and calcium: Physiology of their renal handling and relation to clinical medicine. Arch. Intern. Med. 131: 828–859.
Ikkos, D., R. Lufft, and C. A. Grinzel. 1959. The effect of human growth hormone in man. Acta Endocrinol. (Copenhagen) 32: 341361.
Henneman, P. H., A. P. Forbes, M. Moldawer, E. F. Dempsy, and E. L. Carrol. 1960. Effects of human growth hormone in man. J. Clin. Invest. 39: 1223–1238.
Beck, J. C. 1960. Primate growth hormone studies in man. Metabolism 9: 699–737.
Corvilain, J., and M. Abramov. 1962. Some effects of human growth hormone on renal hemodynamics and on tubular phosphate transport in man. J. Clin. Invest. 41: 1230–1235.
Lambert, P. P., and J. Corvilain. 1963. Site of action of parathyroid hormone and role of growth hormone in phosphate excretion. In: Hormones and the Kidney. P. C. Williams, ed. Academic Press, New York. pp. 139–147.
Corvilain, J., and M. Abramov. 1964. Effect of growth hormone on tubular transport of phosphate in normal and parathyroidectomized dogs. J. Clin, Invest. 43: 1608.
Durand, D., M. Prelot, and Y. Raoul. 1976. Effets precoces de l’hormone de croissance sur les phosphates seriques et urinaires du rat. Experientia 32: 120.
Bijvoet, O. L. M., J. van der Sluys Veer, H. Greven, and A. M. P. Scheliekens. 1972. Influence of calcitonin on renal excretion of sodium and calcium. In: Parathyroid Hormone and the Calcitonin. R. V. Talmage and P. L. Munson, eds. Excerpta Medica, Amsterdam. pp. 284–298.
Hammerman, M. R., I. E. Carl, and K. A. Hruska. 1980. Regulation of canine renal vesicle Pi transport by growth hormone and parathyroid hormone. Biochim. Biophys. Acta 603: 322–325.
Bijvoet, O. L. M., J. Van der Sluys Veer, H. R. de Vries, and A. T. J. van Koppen. 1971. Natriuretic effect of calcitonin in man. N. Engl. J. Med. 284: 681–688.
Singer, F. R., N. J. Woodhouse, D. K. Parkinson, and G. F. Joplin. 1969. Some acute effects of administered porcine calcitonin in man. Clin. Sci. 37: 181–190.
Ardaillou, R. J., J. P. Faillastre, G. Milhaud, R. Rousselet, R. Delaunay, and G. Richet. 1969. Renal excretion of phosphate, calcium and sodium during and after a prolonged thyrocalcitonin infusion in man. Proc. Soc. Exp. Biol. Med. 131: 56–60.
Ardaillou, R., P. Vaugnat, G. Milhaud, and G. Richet. 1967. Effects de la thyrocalcitonine sur l’excretion renale des phosphates, du calcium et des ions H+ chez l’homme. Nephron 4: 298–314.
Paillard, F., R. Ardaillou, H. Malendin, J. P. Fillastre and S. Prier. 1972. Renal effects of salmon calcitonin in man. J. Lab. Clin. Med. 80: 200–216.
Haas, H. G., M. A. Dambacher, J. Guncaga, and T. Lauffenburger. 1971. Renal effects of calcitonin and parathyroid extract in man. J. Clin. Invest. 50: 26–89.
Sorensen, O. H., and I. Hindberg. 1972. The acute and prolonged effect of porcine calcitonin on urine electrolyte excretion in intact and parathyroidectomized rats. Acta Endocrinol. (Copenhagen) 70: 295.
Robinson, C. J., T. J. Martin, and I. McIntyre. 1966. Phosphaturic effect of thyrocalcitonin. Lancet 1: 83.
Milhaud, G., M. L. Mouhktar, G. Cherian, and A. M. Perault. 1966. Effect de l’administration de thyrocalcitonin sur les principaux parametres du metabolisme du calcium du rat normal et du rat thyroparathyroidectomise. C. R. Acad. Sci. 262: 511.
Marx, S. J., and G. D. Aurbach. 1975. Renal receptors for calcitonin: Coordinate occurrence with calcitonin-activated adenylate cyclase. Endocrinology 97: 448.
Marx, S. J., C. J. Woodard, and G. Aurbach. 1972. Calcitonin receptors of kidney and bone. Science 178: 999.
Dousa, T. P. 1974. Effects of hormones on cyclic AMP formation in kidneys of nonmammalian vertebrates. Am. J. Phyisol. 226: 1193.
Ardaillou, R. 1975. Kidney and calcitonin.. Nephron 15: 250.
Heersche, J. N. M., R. Marcus, and G. D. Aurbach. 1974. Calcitonin and the formation of 3’,5’-AMP in bone and kidney. Endocrinology 94: 241.
Kurokawa, K., N. Nagata, M., Sasaki, and K. Nakane. 1974. Effects of calcitonin on the concentration of cyclic adenosine 3’,5’-monophosphate in rat kidney in vivo and in vitro. Endocrinology. 94: 1514.
Gelde, D. 1972. Der Einfluss von synthetischem Calcitonin auf die proximal-tubulare Phosphatresorption. Kiln. Wochenschr. 50: 527.
Deftos, L. J., and J. G. Parthemore. 1974. Secretion of parathyroid hormone in patients with medullary thyroid carcinoma. J. Clin. Invest. 54: 416–420.
Perlzweig, W. A., E. Latham, and C. S. Keefer. 1923. The behavior of inorganic phosphate in the blood and urine of normal and diabetic subjects during carbohydrate metabolism. Proc. Soc. Exp. Biol. Med. 21: 33.
Allen, F. N., B. R. Dickson, and J. Markowitz. 1925. The relationship of phosphate and carbohydrate metabolism. Am. J. Physiol. 70: 333.
Nishimoto, H. 1929. On relation between carbohydrate metabolism and inorganic phosphates. Jpn. J. Exp. Med. 7: 207.
Morey, E. R., and A. D. Kenny. 1964. Effects of catecholamines on urinary calcium and phosphorus in intact and parathyroidectomized rats. Endocrinology 75: 18.
Dousa, T. P., and H. Valtin. 1976. Cellular action of vasopressin in the mammalian kidney. Kidney Int. 10: 46.
Kurokawa, K., and S. G. Massry. 1973. Evidence for stimulation of renal gluconeogenesis by catecholamines. J. Clin. Invest. 52: 961.
Massara, F., and F. Camanni. 1970. Propranolol block of adrenalin-induced hypophosphataemia in man. Clin. Sci. 38: 245.
Body, J. J., P. E. Cryer, K. O. Offord, and H. Heath. 1983. Epinephrine is a hypophosphatemic hormone in man. J. Clin. Invest. 71: 572–578.
Ellis, S. 1956. The metabolic effects of epinephrine and related amines. Pharmacol. Rev. 8: 485.
Levitan, B. A. 1951. Effect in normal man of hyperglycemia and glycosuria on excretion and reabsorption of phosphate. J. Appl. Physiol. 4: 224–226.
Huffman, E. R., C. J. Hlad, Jr., N. E. Whipple, and H. Elrick. 1958. The influence of blood glucose on the renal clearance of phosphate. J. Clin. Invest. 37: 369–379.
Fox, M., S. Thier, and L. Rosenberg. 1964. Impaired renal tubular function induced by sugar infusion in man. J. Clin. Endocrinol. Metab. 24: 1318–1327.
Ginsburg, J. M. 1972. Effect of glucose and free fatty acid on phosphate transport in dog kidney. Am. J. Physiol. 222: 1153–1160.
Pitts, R. F., and R. S. Alexander. 1944. The renal reabsorptive mechanism for inorganic phosphate in normal and acidotic dogs. Am. J. Physiol. 142: 648–662.
Cohen, J., F. Berglund, and W. D. Lotspeich. 1957. Interactions during renal tubular reabsorption in the dog among several anions showing a sensitivity to glucose and phlorizin. Am. J. Physiol. 189: 331–338.
Sohdey, S. S., and F. N. Allan. 1924. The relationship of phosphates to carbohydrate metabolism. I. Time relationship of the changes in phosphate excretion caused by insulin and sugar. Biochem. J. 18: 1170–1184.
Eggleton, M. G., and S. Shuster. 1954. Glucose and phosphate excretion in the cat. J. Physiol. (London) 124: 613–622.
DeFronzo, R. A., C. R. Cooke, R. Andres, and G. R. Faloona. 1975. The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man. J. Clin. Invest. 55: 845855.
DeFronzo, R. A., M. Goldberg, and Z. Agus. 1976. The effects of glucose and insulin on renal electrolyte transport. J. Clin. Invest. 58: 83–90.
Roy, D. R. and J. F. Seeley. 1981. Effect of glucose on renal excretion of electrolytes in the rat. Am. J. Physiol. 240: F17 - F24.
Nizet, A., P. Lefebvre, A. Luyckx, and J. Crabbe. 1977. Hormone and non-specific humoral factors in the interferences between sodium, glucose and phosphate handling by the dog kidney. Curr. Prob. Clin. Biochem. 6: 262–272.
Anderson, J., and J. B. Forster. 1959. Effect of cortisone on urinary phosphate excretion in man, Clin. Sci. 18: 437.
Ingbar, S. H., E. H. Kass, C. H. Burnett, A. S. Reiman, B. A. Burrows, and J. H. Sisson. 1951. The effects of ACTH and cortisone on the renal tubular transport of uric acid, phosphorus, and electrolytes in patients with normal renal and adrenal function. J. Lab. Clin. Med. 38: 533.
Wajchenberg, B. L., E. R. Quintao, B. Liberman, and A. B. U. Cintra. 1965. Antagonism between adrenal steroids and parathyroid hormone. J. Clin. Endocrinol. Metab. 25: 1677.
Roberts, K. E., and R. F. Pitts. 1953. The effects of cortisone and desoxycorticosterone on the renal tubular reabsorption of phosphate and the excretion of titratable acid and potassium in dogs. Endocrinology. 52: 324.
Laron, Z., J. D. Crawford, and R. Klein. 1957. Phosphaturic effect of cortisone in normal and parathyroidectomized rats. Proc. Soc. Exp. Biol. Med. 96: 649.
Thom, G. W., D. Jenkins, J. C. Laidlaw, F. C. Goetz, J. F. Dingman, W. L. Arons, D. H. P. Streeten, and B. H. McCracken. 1953. Pharmacologic aspects of adrenocortical steroids and ACTH in man. N. Engl. J. Med. 248: 141.
Rastegar, A., Z. Agus, T. B. Connor, and M. Goldberg. 1972. Renal handling of calcium and phosphate during mineralocorticoid “escape” in man. Kidney Int. 2: 279.
Pfaundler, M. 1900. Über ein Verfohien zur Bestemmung des Aminosäurenstickstoffs im Harne. Z. Physiol. Chem. 30: 75–89.
Thier. S. O. 1974. Amino acid transport in the renal tubule cell. In: Recent advances in Renal Physiology and Pharmacology. L. G. Wesson and G. M. Fanelli, Jr., eds. University Park Press, Baltimore. pp. 39–51.
Brodehl, J., and K. Gellissen. 1968. Endogenous renal transport of free amino acids in infancy and childhood. Pediatrics 42: 395404.
Bergeron, M., and F. Morel. 1969. Amino acid transport in rat renal tubules. Am. J. Physiol. 216: 1139–1149.
Barfuss, D. W., and J. A. Schafer. 1979. Active amino acid absorption by proximal convoluted and proximal straight tubules. Am. J. Physiol. 236: F149 - F162.
Chan, A. W. K., H. B. Burch, T. R. Alvey, and O. H. Lowry. 1975. A quantitative histochemical approach to renal transport. I. Aspartate and glutamate. Am. J. Physiol. 229: 1034–1044.
Wedeen, R. P., and S. O. Thier. 1971. Intrarenal distribution of nonmetabolized amino acids in vivo. Am. J. Physiol. 220: 507512.
Pitts, R. F. 1943. A renal reabsorptive mechanism in the dog common to glycine and creatinine. Am. J. Physiol. 140: 156–168.
Beyer, K. H., L. D. Wright, H. F. Russo, H. R. Skeggs, and E. A. Patch. 1946. The renal clearance of essential amino acids: Tryptophan, leucine, isoleucine and valine. Am. J. Physiol. 146: 330–335.
Beyer, K. H., L. D. Wright, H. R. Skeggs, H. F. Russo, and G. A. Shaner. 1947. Renal clearance of essential amino acids: Their competition for reabsorption by the renal tubules. Am. J. Physiol. 151: 202–210.
Wright, L. D., H. F. Russo, H. R. Skeggs, E. A. Patch, and K. H. Beyer. 1947. The renal clearance of essential amino acids: Arginine, histidine, lysine and methionine. Am. J. Physiol. 149: 130–134.
Kamin, H., and P. Handler. 1951. Effect of infusion of single amino acids upon excretion of other amino acids. Am. J. Physiol. 164: 654–661.
Gerok, W., and J. Gayer. 1961. Investigations on the reabsorption of amino acids in the kidney of the dog. Proc. 1st Int. Congr. Nephrol. pp. 720–724.
Gerok, W., and J. Gayer. 1961. Die Tubulare Rückresorption der L-Aminosäuren in der Niere des Hundes: Transport-maxima und Competitive Hemmung. Klin. Wochenschr. 39: 540–546.
Gerok, W., and J. Gayer. 1964. Investigations on the reabsorption of L-amino acids in the kidney of the dog with special reference to diaminomonocarbonic acids. Proc. 2nd Int. Congr. Nephrol. pp. 572–574.
Webber, S. W. 1962. Interactions of neutral and acidic amino acids in renal tubular transport. Am. J. Physiol. 202: 577–583.
Webber, W. A. 1963. Characteristics of acidic amino acid transport in mammalian kidney. Can. J. Biochem. Physiol. 41: 131–137.
Webber, W. A., J. L. Brown, and R. F. Pitts. 1961. Interactions of amino acids in renal tubular transport. Am. J. Physiol. 200: 380–386.
Scriver, C. R., M. L. Efron, and J. A. Schafer. 1964. Renal tubular transport of proline, hydroxyproline, and glycine in health and in familial hyperprolinemia. J. Clin. Invest. 43: 374–385.
Rosenberg, L. E., A. Blair, and S. Segal. 1961. The transport of amino acids by rat kidney cortex slices. Biochim. Biophys. Acta 54: 479–488.
Fox, M., S. O. Thier, L. E. Rosenberg, and S. Segal. 1964. Ionic requirements for amino acid transport in the rat kidney cortex slice. I. Influence of extracellular ions. Biochim. Biophys. Acta 79: 167–176.
Thier, S. O., A. Blair, M. Fox, and S. Segal. 1967. The effect of extracellular sodium on the kinetics of AIB transport in rat kidney cortex slice. Biochim. Biophys. Acta 135: 300–305.
Wedeen, R. P., and S. O. Thier. 1971. Intrarenal distribution of 512.
Wedeen, R. P., and B. Weiner. 1973. The distribution of paminohippuric acid in rat kidney slices. I. Tubular localization. Kidney Int. 3: 205–213.
Wedeen, R. P., and B. Weiner. 1973. The distribution of paminohippuric acid in rat kidney slices. II. Depth of uptake. Kidney Int. 3: 214–221.
Barfuss, D. W., J. M. Mays, and J. A. Schafer. 1980. Peritubular uptake and transepithelial transport of glycine in isolated proximal tubules. Am. J. Physiol. 238: F224 - F333.
Ausiello, D. A., S. Segal, and S. O. Thier. 1972. Cellular accumulation of L-lysine in rat kidney cortex in vivo. Am. J. Physiol. 222: 1473–1478.
Grcth, W. E., S. O. Thier, and S. Segal. 1973. Cellular accumulation of L-cystine in rat kidney cortex in vivo. J. Clin. Invest. 52: 454–462.
Foulkes, E. C. 1972. Cellular localization of amino acid carriers in renal tubules. Proc. Soc. Exp. Biol. Med. 129: 1032–1033.
Bergeron, M., and M. Vandeboncoeur. 1971. Antiluminal transport of L-arginine and L-leucine following microinjections in peritubular capillaries of the rat. Nephron 8: 355–366.
Sacktor, B. 1977. Transport in membrane vesicles isolated from the mammalian kidney and intestine. Curr. Top. Bioenerg. 6: 39–81.
Reynolds, R. A., H. Wald, P. D. McNamara, and S. Segal. 1980. An improved method for isolation of basolateral membranes from rat kidney. Biochim. Biophys. Acta 601: 92–100.
McNamara, P. D., B. Ozegovic, L. M. Pepe, and S. Segal. 1976. Proline and glycine uptake by renal brushborder membrane vesicles. Proc. Natl. Acad. Sci. USA 73: 4521–4525.
Hammerman, M. R., and B. Sacktor. 1977. Transport of amino acids in renal brush border membrane vesicles. J. Biol. Chem. 252: 591–595.
McNamara, P. D., L. M. Pepe, and S. Segal. 1979. Sodium gradient dependence of proline and glycine uptake in rat renal brush-border membrane vesicles. Biochim. Biophys. Acta 556: 151–160.
Foulkes. E. C., and T. Gieske. 1973. Specificity and metal sensitivity of renal amino acid transport. Biochim. Biophys. Acta 318: 439–445.
Jepson, J. B. 1972. Hartnup disease. In: The Metabolic Basis of Inherited Disease, 3rd ed. J. B. Stanbury, J. B. Wyngaarden, and D. S. Fredrickson, eds. McGraw-Hill, New York. pp. 1486–1503.
Baron, D. N., C. E. Dent, H. Harris, E. W. Hart, and J. B. Jepson. 1956. Hereditary pellagra-like skin rash with temporary cerebellar ataxia, constant renal aminoaciduria, and other bizarre biochemical features. Lancet 1: 421–428.
Milne, M. D., M. A. Crawford, C. B. Girao, and L. Loughridge. 1960. The metabolic disorder in Hartnup disease. Am. J. Med. 29: 407–412.
Scriver, C. R. 1965. Hartnup disease: A genetic modification of intestinal and renal transport of certain neutral alpha-amino acids. N. Engl. J. Med. 273: 530–532.
Shih, V. E., E. M. Bixby, D. H. Alpers, C. S. Bartsocas, and S. O. Thier. 1971. Studies of intestinal transport defect in Hartnup disease. Gastroenterology 61: 445–453.
Navab, F., and A. M Asatoor. 1970. Studies on intestinal absorption of amino acids and a dipeptide in a case of Hartnup disease. Gut 11: 373–379.
Winter, C. G., and H. N. Christensen. 1965. Contrasts in neutral amino acid transpon by rabbit erythrocytes and reticulocytes. J. Biol. Chem. 240: 3594–3600.
Rosenberg, L. E., and C. R. Scriver. 1974. Disorders of amino acid metabolism. In: Duncan’s Diseases of Metabolism: Genetics and Metabolism. P. K. Bondy and L. E. Rosenberg, eds. Saunders, Philadelphia. pp. 465–654.
Milne, M. D. 1972. Renal tubular dysfunction. In: Diseases of the Kidney, 2nd ed. M. B. Strauss and L. G. Welt, eds. Little, Brown, Boston. pp. 1071–1138.
Halvorsen, K., and S. Halvorsen. 1963. Hartnup disease. Pediatrics 31: 29–38.
Hooft, C., J. Timmenons, J. Snoeck, I. Anterer, W. Ouaert, and C. H. Vanden-Hends. 1964. Methionine malabsorption in a mentally defective child. Lancet 2: 20.
Drummond, K. N., A. F. Michael, R. A. Ulstrom, and R. A. Good. 1964. The blue diaper syndrome: Familial hypercalcemia with nephrocalcinosis and indicanaemia. Am. J. Med. 37: 928–948.
Sabater, J., C. Ferre, M. Puliol, and A. Maya. 1976. Histidinuria: A renal and intestinal histidine transport deficiency found in two mentally retarded children. Clin. Genet. 9: 117–124.
Thier, S. O., and S. Segal. 1972. Cystinuria. In: The Metabolic Basis of Inherited Disease, 3rd ed. J. B. Stanbury, J. B. Wyngaarden, and D. S. Fredrickson, eds. McGraw-Hill, New York. p. 1504.
Garrod, A. E. 1908. The Croonian lectures. Lancet 2:1, 73, 142, 214.
Dent, C. E., J. G. Heathcote, and G. E. Joron. 1954. The pathogenesis of cystinuria. I. Chromatographic and microbiological studies of the metabolism of sulphur-containing amino acids. J. Clin. Invest. 33: 1210–1215.
Dent, C. E., B. Senior, and J. M. Walshe. 1954. The pathogenesis of cystinuria. II. Polarographic studies of the metabolism of sulphur-containing amino acids. J. Clin. Invest. 33: 1216–1226.
Crawhall, J. C., E. F. Scowen, C. J. Thompson, and R. W. E. Watts. 1967. The renal clearance of amino acids in cystinuria. J. Clin. Invest. 46: 1162–1171.
Rosenberg, L., S. Downing, and S. Segal. 1962. Competitive inhibition of dibasic amino acid transport in rat kidney. J. Biol. Chem. 237: 2265–2270.
Fox, M., S. O. Thier, L. E. Rosenberg, W. Kiser, and S. Segal. 1964. Evidence against a single renal transport defect in cystinuria. N. Engl. J. Med. 270: 556–561.
Foreman, J. W., S. M. Hwang, and S. Segal. 1980. Transport interactions of cystine and dibasic amino acids in isolated rat renal tubules. Metabolism 29: 53–61.
Segal, S., P. D. McNamara, and L. M. Pepe. 1977. Transport interaction of cystine and dibasic amino acids in renal brush border vesicles. Science 197: 169–171.
McNamara, P. D., L. M. Pepe, and S. Segal. 1981. Cystine uptake by rat renal brush-border vesicles. Biochem. J. 194: 443449.
Rosenberg, L. E., and S. J. Downing. 1965. Transport of neutral and dibasic amino acids by human leukocytes: Absence of defect in cystinuria. J. Clin. Invest. 44: 1382–1393.
Crawhall, J. C., and S. Segal. 1966. The intracellular cysteine/cystine ratio in kidney cortex. Biochem. J. 99: 19c - 20c.
Crawhall, J. C., and S. Segal. 1967. Intracellular ratio of cystine and cysteine in various tissues. Biochem. J. 105: 891–896.
Schwartzman, L., A. Blair, and S. Segal. 1966. A common renal transport system for lysine, ornithine, arginine and cysteine. Biochem. Biophys. Res. Commun. 23: 220–226.
Milne, M. D., A. M. Asatoor, K. D. G. Edwards, and L. W. Loughridge. 1961. The intestinal absorption defect in cystinuria. Gut 2: 323–337.
Asatoor, A. M., B. W. Lacey, D. R. London, and M. D. Milne. 1962. Amino acid metabolism in cystinuria. Clin. Sci. 23: 285304.
Thier, S., M. Fox, S. Segal, and L. E. Rosenberg. 1964. Cystinuria: In vitro demonstration of an intestinal transport defect. Science 143: 482–484.
Thier, S. O., S. Segal, M. Fox, A. Blair, and L. E. Rosenberg.
Cystinuria: Defective intestinal transport of dibasic amino acids and cystine. J. Clin. Invest. 44: 442–448.
McCarthy, C. F., J. L. Borland, H. J. Lynch, E. E. Owen, and M. P. Tyor. 1964. Defective uptake of basic amino acids and Lcystine by intestinal mucosa of patients with cystinuria. J. Clin. Invest. 43: 1518–1524.
Alpers, D. H., and S. O. Thier. 1972. Role of the free amino acid pool of the intestine in protein synthesis. Biochim. Biophys. Acta 262: 535–545.
Harris, H., U. Mittwoch, E. B. Robson, and F. L. Warren. 1955. Pattern of amino acid excretion in cystinuria. Ann. Hum. Genet. 12: 195–208.
Harris, H., U. Mittwoch, E. B. Robson, and F. L. Warren. 1955: Phenotypes and genotypes in cystinuria. Ann. Hum. Genet. 20: 57–91.
Rosenberg, L. E., S. J. Downing, J. L. Durant, and S. Segal. 1966. Cystinuria: Biochemical evidence for three genetically distinct diseases. J. Clin. Invest. 45: 365–371.
Rosenberg, L. E. 1967. Genetic heterogeneity in cystinuria. In: Amino Acid Metabolism and Genetic Variation. W. L. Nyhan, ed. McGraw-Hill, New York. p. 341.
Hershko, C., E. Ban-Ami, J. Paciorkovski, and N. Levin. 1965. Alleomorphism in cystinuria. Proc. Tel-Hashomer Hosp. 4: 21.
Crawhall, J. C., E. F. Scowen, and R. W. E. Watts. 1963. Effect of penicillamine on cystinuria. Br. Med. J. 1: 588–590.
King, J. S. 1968. Treatment of cystinuria with alpha-mercaptopropionylgylcine: A prelminary report. Proc. Soc. Exp. Biol. Med. 129: 927–932.
Kinoshita, K., S. Yachiku, T. Kotake, M. Takeuchi, and T. Sonoda. 1972. Treatment of cystinuria with 2-mercaptopropionylglycine (MPG). Proc. 2nd Int. Symp. Thiola. Osaka, Santen Pharmaceutical Co. p. 50.
Sonoda, T., K. Kinoshita, T. Kotake, S. Yachiku, and M. Takeuchi. 1970. Effect of thiola on cystinuria. Proc. Int. Symp. Thiola. Osaka, Santen Pharmaceutical Co. p. 231.
Nishimura, R., T. Ishido, and S. Takai. 1972. Studies on cystinuria. Proc. 2nd. Int. Symp. Thiola. Osaka, Santen Pharmaceutical Co. p. 47.
Hautmann, R., B. Terhorst, H. W. Stuhlsatz, and W. Lutzeyer. 1977. Mercaptopropionylgylcine: A process in cystine stone therapy. J. Urol. 117: 628–630.
Kallistratos, G., I. Mita, and V. Vadaloyka-Kalfakakou. 1979. Management of cystinuric disorders with sulfhydryl drugs. In: The Management of Genetic Disorders. C. J. Papadotos and C. S. Bartsocas, eds. Liss, New York. pp. 255–263.
Lucky, P. A., F. Skovby, and S. O. Thier. 1983. Pemphigus foliaceus and proteinuria induced by alpha-mercaptopropionylglycine. J. Am. Acad. Dermatol. 8: 667–672.
Pak, C. Personal communication.
Miyagi, K., F. Nakada, and S. Ohshiro. 1979. Effect of glutamine on cystine excretion in a patient with cystinuria. N. Engl. J. Med. 301: 196–198.
Skovby, F., L. E. Rosenberg, and S. O. Thier. 1980. No effect of L-glutamine on cystinuria. [Letter to the Editor]. N. Engl. J. Med. 302: 236–237.
Joost, J., and E. Jarosch. 1981. Glutamine: A new anticystinuric drug? Eur. Urol. 7: 363–364.
Van Den Berg, C. J., J. D. Jones, D. M. Wilson, and L. H. Smith. 1980. Glutamine therapy of cystinuria. Invest. Urol. 18: 155–157.
Kekkomäki, M., J. K. Visakorpi, J. Perheentupa, and L. Saxen. 1967. Familial protein intolerance with deficient transport of basic amino acids: An analysis of ten patients. Acta Paediatr. Scand. 56: 617–630.
Whelan, D. T., and C. R. Scriver. 1968. Hyperdibasicaminoaciduria: An inherited disorder of amino acid transport. Pediatr. Res. 2: 525–534.
Brodehl, J., K. Gallissen, and S. Kowalewski. 1967. Isolated cystinuria (without lysine-ornithine-argininuria) in a family with hypocalcemic tetany. Klin. Wochenschr. 45: 38–40.
Oyanagi, K., H. Sogawa, R. Minami, T. Nakao, and T. Chiba. 1979. The mechanism of hyperammonemia in congenital lysinuria. J. Pediatr. 94: 255–256.
Desjeux, J.-F., J. Rajantie, O. Simell, A.-M. Dumontier, and J. Perheentupa. 1980. Lysine fluxes across the jejunal epithelium in lysinuric protein intolerance. J. Clin. Invest. 65: 1382–1387.
Simell, O., and J. Perheentupa. 1974. Renal handling of diamino acids in lysinuric protein intolerance. J. Clin. Invest. 54: 9–17.
Tada, K., T. Morikawa, T. Ando, T. Yoshida, and A. Minagawa. 1965. Prolinuria: A new renal tubular defect in transport of proline and glycine. Tohoku J. Exp. Med. 87: 133–143.
Scriver, C. R., and O. H. Wilson. 1967. Amino acid transport: Evidence for genetic control of two types in human kidney. Science 155: 1428–1430.
Hillman, R. E., and L. E. Rosenberg. 1969. Amino acid transport by isolated mammalian renal tubules. II. Transport systems for Lproline. J. Biol. Chem. 244: 4494–4498.
Mohyuddin, F., and C. R. Scriver. 1970. Amino acid transport in mammalian kidney: Identification and analysis of multiple systems for imino acids and glycine in rat kidney. Am. J. Physiol. 219: 1–8.
deVries, A., S. Kochwa, J. Lazebink, M. Frank, and M. Djaldetti. 1957. Glycinuria, a hereditary disorder associated with nephrolithiasis. Am. J. Med. 23: 408–415.
Greene, M. L., P. S. Lietman, L. E. Rosenberg, and J. E. Seegmiller. 1973. Familial hyperglycinuria: New defect in renal tubular transport of glycine and the imino acids. Am. J. Med. 54: 265–271.
Morikawa, T., K. Tada, T. Ando, T. Yoshida, Y. Tokoyama, and T. Arakawa. 1966. Prolinuria: Defect in intestinal absorption of imino acids and glycine. Tohoku J. Exp. Med. 90: 1051–16.
Goodman, S. I., C. A. McIntyre, and D. O’Brien. 1967. Impaired intestinal transport of proline in a patient with familial iminoaciduria. J. Pediatr. 71: 246–249.
Teijema, H. L., H. H. van Gelderen, M. A. H. Giesberts, and S. L. Laurent de Angulo. 1974. Dicarboxylic aminoaciduria: An inborn error of glutamate and aspartate transport with metabolic implications, in combination with a hyperprolinemia. Metabolism. 23: 115.
Melancon, S. B., L. Dallaire, B. Lemieux, P. Robitaille, and M. Potier. 1977. Dicarboxylic aminoaciduria: An inborn error of amino acid conservation. J. Pediatr. 91: 422–427.
Thier, S. O. 1970. Genetic control of amino acid transport in gut and kidney. Birth Defects: Orig. Artic. Ser. 6 (3): 20–21.
Scriver, C. R., S. Pueschel, and E. Davies. 1966. Hyper-betaalaninemia associated with beta-aminoaciduria and gamma-aminobutyricaciduria, somnolence and seizures. N. Engl. J. Med. 274: 636–643.
Fanconi, G. 1936. Der Nephrotisch-glykosurische Zwergwuchs mit Hypophosphatamischer Rachitis. Dtsch. Med. Wochenschr. 62: 1169–1171.
Clay, R. D., E. M. Darmady, and M. Hawkins. 1953. The nature of the renal lesion in Fanconi syndrome. J. Pathol. Bacteriol. 65: 551–558.
Darmady, E. M., and F. Stranack. 1957. Microdissection of the nephron in disease. Br. Med. Bull. 13: 21–25.
Wallis, L. A., and R. L. Engle. 1957. Multiple myeloma and the adult Fanconi syndrome. Am. J. Med. 22: 5–12.
Costanza, D. J., and M. Smollen. 1963. Multiple myeloma with the Fanconi syndrome. Am. J. Med. 34: 125–133.
Jackson, J. D., F. G. Smith, N. N. Litman, C. L. Yuile, and H. Latta. 1962. The Fanconi syndrome with cystinosis. Am. J. Med. 33: 893–910.
Gentz, J., R. Jagenburg, and R. Zetterstrom. 1965. Tyrosinemia, an inborn error of tyrosine metabolism with cirrhosis of the liver and multiple renal tubular defects. J. Pediatr. 66: 670–696.
Cusworth, D. C., C. E. Dent, and F. V. Flynn. 1955. The aminoaciduria in galactosemia. Arch. Dis. Child. 30: 150–154.
Morris, R. C., L. Ueki, D. Loh, R. L. Eanes, and P. McLin. 1967. Absence of renal fructose-1-phosphate aldolase activity in hereditary fructose intolerance. Nature (London) 214: 920–921.
Morgan, H. G., W. K. Stewart, K. G. Lowe, J. M. Stowers, and J. H. Johnstone. 1962. Wilson’s disease and the Fanconi syndrome. Q. J. Med. 31: 361–384.
Lee, D. B. N., J. P. Drinkard, V. J. Rosen, and H. C. Gonizk. 1972. The adult Fanconi syndrome. Medicine (Baltimore) 51: 107–138.
Chisolm, J. J., H. C. Harrison, W. R. Eberlein, and H. E. Harrison. 1955. Aminoaciduria, hypophosphatemia, and rickets in lead poisoning. Am. J. Dis. Child. 89: 159–168.
Morgan, J. M., M. W. Hartley, and R. E. Miller. 1966. Nephropathy in chronic lead poisoning. Arch. Intern. Med. 118: 17–29.
Worthen, H. G. 1963. Renal toxicity to maleic acid in the rat: Enzymatic and morphologic observations. Lab. Invest. 12: 79 1801.
Bergeron, M., and P. Laporte. 1973. Effet membranaire du male-ate au niveau du nephron proximal et distal. Rev. Can. Biol. 32: 275–279.
Kramer, J. H., and H. C. Gonick. 1970. Experimental Fanconi syndrome. I. Effect of maleic acid on renal cortical Na-K-ATPase activity and ATP-levels J. Lab. Clin. Med. 76: 799–808.
Bergeron, M., L. Dubord, and C. Hausser. 1976. Membrane permeability as a cause of transport defects in experimental Fanconi syndrome. J. Clin. Invest. 57: 1181–1189.
Rosenberg, L. E., and S. Segal. 1964. Maleic acid-induced inhibition of amino acid transport in rat kidney. Biochem. J. 92: 345–352.
Bovee, K. C., T. Joyce, R. Reynolds, and S. Segal. 1978. The Fanconi syndrome in basenji dogs: A new model for renal transport defects. Science 201: 1129–1131.
Omura, K., N. Yamanaka, S. Higami, O. Matsuoka, A. Fujimoto, G. Issiki, and K. Tada. 1976. Lysine malabsorption syndrome: A new type of transport defect. Pediatrics 57: 102–105.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Plenum Publishing Corporation
About this chapter
Cite this chapter
DeFronzo, R.A., Their, S.O. (1987). Renal Tubular Defects in Phosphate and Amino Acid Transport. In: Andreoli, T.E., Hoffman, J.F., Fanestil, D.D., Schultz, S.G. (eds) Clinical Disorders of Membrane Transport Processes. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-1286-4_14
Download citation
DOI: https://doi.org/10.1007/978-1-4684-1286-4_14
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-42699-5
Online ISBN: 978-1-4684-1286-4
eBook Packages: Springer Book Archive